SCHEMBL365569

SCHEMBL365569

CC(C)[C@H]1CC[C@@H](C)C/C=C(/O)[C@H](C)CC1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
TRPA1 O75762 2/20 0.32
TRPM8 Q7Z2W7 2/20 0.32
TRPV1 Q8NER1 2/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17913073 0.79
SCHEMBL17913074 0.79
SCHEMBL4998358 0.78
Hydrogen Peroxide SCHEMBL65467 0.69 TRPA1 (0.41) ROCK2ROCK1TRPA1TRPM8EPHX1
SCHEMBL1760669 0.68 TRPA1 (0.39) TRPA1TRPM8EPHX1
SCHEMBL452781 0.68 TRPA1 (0.39) TRPA1TRPM8EPHX1
SCHEMBL7979 0.68 TRPA1 (0.39) TRPA1TRPM8EPHX1
Bicarbonate SCHEMBL10767839 0.68 EPHX1 (0.39) ROCK2ROCK1TRPA1TRPM8TRPV1
Phenol SCHEMBL5475642 0.67 ESR2 (0.46) ROCK2ROCK1TRPM8
Charcoal, Activated SCHEMBL4530459 0.66 TRPA1 (0.37) TRPA1TRPM8EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1916307-B1 Plant enzymes for bioconversion DAFRA PHARMA RES & DEV BVBA (BE) 2014-02-26 EP disclosed
US-8163980-B2 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-04-24 US disclosed
US-8097438-B2 Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-17 US disclosed
WO-2011121456-A2 NUCLEIC ACIDS AND PROTEIN SEQUENCES OF COSTUNOLIDE SYNTHASE UTI LIMITED PARTNERSHIP (CA) 2011-10-06 WO disclosed
US-20110008829-A1 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-01-13 US disclosed
US-20080124772-A1 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. 2008-05-29 US disclosed
EP-1916307-A1 Plant enzymes for bioconversion Plant Research International B.V. (NL) 2008-04-30 EP disclosed
US-20070300327-A1 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. 2007-12-27 US disclosed
US-7214507-B2 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. (NL) 2007-05-08 US disclosed
US-20050019882-A1 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) 2005-01-27 US disclosed
EP-1427838-A1 PLANT ENZYMES FOR BIOCONVERSION Plant Research International B.V. (NL) 2004-06-16 EP disclosed
WO-2003025193-A1 PLANT ENZYMES FOR BIOCONVERSION PLANT RESEARCH INTERNATIONAL B.V. (NL) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124772-A1 Plant enzymes for bioconversion STS, SQLE, CYP51A1 ROCK2 2628/4885ROCK1 2804/4885TRPA1 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.